PT Tempo Scan Pacific Tbk (PEXXF) Aktienanalyse

PT Tempo Scan Pacific Tbk (PEXXF) Gesundheitswesen & Pipeline-Uebersicht

PT Tempo Scan Pacific Tbk, an Indonesian-based company, manufactures and distributes pharmaceuticals, consumer products, and cosmetics, leveraging a strong brand portfolio including Bodrex and Marina, and a wide distribution network to serve both domestic and international markets within the healthcare and personal care sectors.

Investmentthese

PT Tempo Scan Pacific Tbk presents a compelling investment case based on its established market position, diverse product portfolio, and extensive distribution network. The company's attractive P/E ratio of 7.51 and a high dividend yield of 8.00% suggest potential value for investors. A profit margin of 11.0% and gross margin of 37.2% reflect solid profitability. Growth catalysts include expanding its product lines and penetrating new international markets. However, investors may want to evaluate the risks associated with operating in a competitive market and potential regulatory changes in the pharmaceutical and consumer goods industries. The company's beta of 0.60 indicates lower volatility compared to the overall market.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

• Market Cap of $0.46B indicates a mid-sized company with potential for growth.
• P/E ratio of 7.51 suggests the company may be undervalued compared to its earnings.
• Profit Margin of 11.0% demonstrates efficient operations and profitability.
• Gross Margin of 37.2% reflects the company's ability to manage production costs effectively.
• Dividend Yield of 8.00% provides a significant return for investors, indicating a commitment to shareholder value.

Wettbewerber & Vergleichsunternehmen

Staerken

• Strong brand recognition in Indonesia.
• Extensive distribution network.
• Diverse product portfolio.
• Established market position.

Schwaechen

• Dependence on the Indonesian market.
• Limited international presence compared to global competitors.
• Potential vulnerability to regulatory changes.
• Exposure to currency fluctuations.

Katalysatoren

• Upcoming: Potential new product launches in the pharmaceutical and consumer goods segments within the next 12-18 months.
• Ongoing: Expansion of distribution network in Southeast Asia to increase market reach.
• Ongoing: Investments in research and development to drive innovation and product differentiation.
• Upcoming: Potential partnerships with e-commerce platforms to boost online sales.
• Ongoing: Government initiatives to improve healthcare access in Indonesia.

Risiken

• Potential: Increasing competition from local and international players in the pharmaceutical and consumer goods industries.
• Potential: Regulatory changes in the pharmaceutical and consumer goods sectors that could impact profitability.
• Potential: Economic downturns in Indonesia and other key markets that could reduce consumer spending.
• Ongoing: Currency fluctuations that could affect the company's financial performance.
• Ongoing: Risks associated with operating in the OTC market, including limited liquidity and disclosure.

Wachstumschancen

• Expanding Product Lines: PT Tempo Scan Pacific Tbk has the opportunity to expand its product lines within the pharmaceutical and consumer goods segments. By investing in research and development, the company can introduce new products that cater to evolving consumer needs and preferences. The market for innovative healthcare and personal care products is growing, presenting a significant opportunity for PT Tempo Scan Pacific Tbk to increase its market share. This expansion can be achieved within the next 2-3 years with sufficient investment in R&D.
• Penetrating New International Markets: PT Tempo Scan Pacific Tbk can leverage its existing distribution network to penetrate new international markets. Southeast Asia, in particular, offers significant growth potential due to its large population and increasing demand for healthcare and consumer goods. By tailoring its products to local preferences and establishing strategic partnerships, the company can successfully expand its international presence. This expansion could begin within the next year, focusing initially on neighboring countries.
• Leveraging E-commerce Platforms: The increasing adoption of e-commerce in Indonesia and other Southeast Asian countries presents a significant growth opportunity for PT Tempo Scan Pacific Tbk. By partnering with leading e-commerce platforms and developing its own online sales channels, the company can reach a wider customer base and increase its sales. The e-commerce market in Indonesia is projected to grow significantly in the coming years, making this a strategic area for investment. This initiative can be implemented within the next 6-12 months.
• Focusing on Herbal and Natural Products: With growing consumer interest in natural and herbal products, PT Tempo Scan Pacific Tbk can capitalize on this trend by expanding its range of herbal and natural remedies. By leveraging its existing brands and distribution network, the company can effectively market these products to health-conscious consumers. The market for herbal and natural products is expanding rapidly, presenting a significant opportunity for PT Tempo Scan Pacific Tbk to increase its market share. This can be achieved through targeted marketing campaigns and product development over the next 1-2 years.
• Strengthening Distribution Network: PT Tempo Scan Pacific Tbk can further strengthen its distribution network by investing in logistics and infrastructure. By improving its supply chain efficiency and expanding its distribution reach, the company can ensure that its products are readily available to customers across Indonesia and other markets. A robust distribution network is crucial for maintaining a competitive edge in the consumer goods and pharmaceutical industries. This ongoing effort will solidify the company's market position.

Chancen

• Expanding into new international markets.
• Developing new products and formulations.
• Leveraging e-commerce platforms.
• Capitalizing on the growing demand for herbal and natural products.

Risiken

• Increasing competition from local and international players.
• Changing consumer preferences.
• Economic downturns in Indonesia and other markets.
• Regulatory challenges and compliance costs.

Wettbewerbsvorteile

• Strong brand recognition in Indonesia and other markets.
• Extensive distribution network across Indonesia.
• Diverse product portfolio spanning pharmaceuticals, personal care, and cosmetics.
• Established relationships with retailers and distributors.

Ueber PEXXF

PT Tempo Scan Pacific Tbk, founded in 1970 and headquartered in Jakarta, Indonesia, has evolved into a prominent player in the pharmaceuticals, personal care, and distribution services industries. Originally known as PT Scanchemie, the company has grown into a diverse conglomerate with a significant presence in Indonesia and internationally. Its operations are divided into three main segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. The Pharmaceuticals segment focuses on the manufacturing and trading of pharmaceutical products and medical devices. The Consumer Products and Cosmetics segment produces a wide range of personal care items, cosmetics, and household products. These products are sold under well-known brands such as Bodrex, Oskadon, Marina, and MY BABY. The Distribution Services segment supports the company's operations through warehousing, freight forwarding, and marketing activities. PT Tempo Scan Pacific Tbk is a subsidiary of PT Bogamulia Nagadi, which provides a stable ownership structure. The company's commitment to research and development, combined with its extensive distribution network, positions it as a key player in the Indonesian market.

Was das Unternehmen tut

• Manufactures and trades pharmaceutical products and medical devices.
• Produces and distributes personal care items, cosmetics, and household products.
• Sells products under brands like Bodrex, Marina, and MY BABY.
• Provides warehousing and freight forwarding services.
• Engages in advertising and promotion activities.
• Conducts research and development for new products and formulations.
• Offers information technology and communication network systems services.
• Procures, distributes, and markets products.

Geschaeftsmodell

• Manufacturing and selling pharmaceutical products and medical devices.
• Producing and distributing consumer products, cosmetics, and household items.
• Providing distribution and logistics services to support its operations.
• Generating revenue through a diverse portfolio of brands and products.

Branchenkontext

PT Tempo Scan Pacific Tbk operates in the competitive pharmaceutical and consumer goods industries in Indonesia and internationally. The Indonesian pharmaceutical market is experiencing growth driven by increasing healthcare awareness and government initiatives to improve access to healthcare. The consumer goods sector is also expanding due to rising disposable incomes and changing consumer preferences. PT Tempo Scan Pacific Tbk competes with both local and international players, including AIHLF, CCHWF, CKDXF, DFHL, and ORRRY. The company's established brands and distribution network provide a competitive advantage in this dynamic market.

Wichtige Kunden

• Consumers in Indonesia and international markets.
• Retailers and distributors who sell PT Tempo Scan Pacific Tbk's products.
• Hospitals and clinics that use the company's pharmaceutical products.
• E-commerce platforms and online retailers.

Finanzdaten

Chart & Info

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer PEXXF verfuegbar.

Analystenkonsens

MoonshotScore

Was Anleger ueber PT Tempo Scan Pacific Tbk (PEXXF) wissen wollen

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Popular Stocks